Polycystic ovary syndrome (PCOS) is a complex syndrome involving both endocrine and metabolic disorders. Gut microbiota and the intestinal immune factor IL-22 play an important role in the pathogenesis of PCOS. However, the therapeutic role of IL-22 in high androgen-induced PCOS mice is not clear. We aimed to determine the therapeutic effects of IL-22 on the dehydroepiandrosterone (DHEA)-induced PCOS mouse model and to explore the possible mechanism of IL-22 in regulating hyperandrogenism-associated PCOS. Insulin resistance levels and ovarian functions were detected in DHEA-induced PCOS mice with or without additional IL-22 treatment. We found that IL-22 could reverse the insulin resistance, the disturbed estrous cycle, abnormal ovary morphology, decreased embryo number in DHEA mice. Mechanistically, IL-22 upregulated the browning of white adipose tissue in DHEA mice. This study demonstrated that IL-22-associated browning of white adipose tissue regulated insulin sensitivity and ovarian functions in PCOS, suggesting that IL-22 may be of value for the treatment of PCOS with a hyperandrogenism phenotype.
THE DEVELOPMENT AND ASSESSMENT OF A SCALE TO MEASURE THE EXPERIENCE OF AN ANOREXIC VOICE IN ANOREXIA NERVOSA.
May 28, 2020
Comparison of post-stent optical coherence tomography findings among three subtypes of calcified culprit plaques in patients with acute coronary syndrome.
March 18, 2020
Effect of flap homogeneity on higher-order aberrations induction after femtosecond LASIK for myopia.
September 10, 2020
- ENDO: 2020ENDO 2020 Annual Conference has been canceled due to COVID-19. Here are highlights of emerging data that has still been released. Keep an eye out for ENDO Online 2020, which will take place from June 8 to 22.